send to a friend by email

JPH posts net income of $7.40 million in 9M 2025

2025-11-11

According to the financial statements for Jerusalem Pharmaceuticals JPH of 30/09/2025 Net profit after tax reached 7,402,153 USD, compared with Net profit after tax of 2,569,215 USD of year 2024 a net increase of 188.11%. Total assets reached 106,683,612 USD, compared with Total assets of 89,154,171 USD at the end of year 2024 a net increase of 19.66%. Total Liabilities reached 23,712,344 USD, compared with Total Liabilities of 17,547,164 USD at the end of year 2024 a net increase of 35.13%. Total Owners' Equity reached 82,971,268 USD including Non-Controlling Interests of 1,057,284 USD, compared with Total Owners' Equity of 71,607,007 USD including Non-Controlling Interests of 1,010,817 USD at the end of year 2024 a net increase of 15.87%.